
EU-funded biotechnology researchers have developed a novel treatment for atherosclerosis, the narrowing and hardening of arteries that is the leading underlying cause of death and disability in Europe.Powered by WPeMatico
Good news from around Europe

EU-funded biotechnology researchers have developed a novel treatment for atherosclerosis, the narrowing and hardening of arteries that is the leading underlying cause of death and disability in Europe.Powered by WPeMatico